Drug Sensitivity Score (DSS) Analysis

SO Sunday Okutachi
GM Ganesh Babu Manoharan
AK Alexandros Kiriazis
CL Christina Laurini
MC Marie Catillon
FM Frank McCormick
JY Jari Yli-Kauhaluoma
DA Daniel Abankwa
request Request a Protocol
ask Ask a question
Favorite

To quantitatively profile the drug sensitivity with a more robust parameter than the IC50 or EC50 values, the drug sensitivity score (DSS) analysis was employed. DSS values are essentially normalized area under the curve (AUC) measures of dose-response inhibition data (Yadav et al., 2014). Drug response data files (in Excel) ready for online analysis were prepared according to the example file obtained from the DSS pipeline website, called Breeze1 (Potdar et al., 2020). Either raw fluorescence intensity measurements or normalized % inhibition data (for BRET assay analysis) were uploaded.

The output file provides several drug sensitivity measures including EC50 and AUC. We plotted the DSS3 value (Yadav et al., 2014), which was calculated as

where DSS2 is given by the equation DSS2=DSS1loga

and DSS1 is given by the equation DSS1=AUC-t(x2-x1)(100-t)(Cmax-Cmin)

DSS3 was employed to emphasize drugs that obtain their response area over a relatively wide dose window, as compared to drugs that show increased response only at the higher end of the concentration range. After logistic fitting of the dose-response inhibition data, the area under the curve (AUC) was determined as the exact solution. A 10% minimal activity threshold (t) was set. The maximum (Cmax) and minimum (Cmin) concentrations were used for screening of the inhibitors, with Cmax = x2 and x1 concentration with minimal activity t. The parameter a is the value of the top asymptote, which can be different from 100% inhibition as obtained from 100 μM benzethonium chloride treatment.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A